FDA Takes Steps to Boost Generic Competition, Limit Prices - KTVN Channel 2 - Reno Tahoe Sparks News, Weather, Video

FDA Takes Steps to Boost Generic Competition, Limit Prices

Posted: Updated:

The Food and Drug Administration said it's taking steps to boost the number of generic prescription drugs on the market in an effort to make medicines more affordable and to prevent price gouging.

Copycat pills generally have been much cheaper than original brand-name drugs. But recent high-profile cases have shown how lack of competition and medicine shortages allowed several drug companies to drastically increase prices for generics and some older brand-name products such as EpiPen emergency allergy injectors.

New FDA commissioner Dr. Scott Gottlieb made addressing prices a priority, saying that agency can help by increasing market competition. While the FDA reviews and approves medications, it doesn't have the power to regulate prices.

"No patient should be priced out of the medicines they need, and as an agency dedicated to promoting public health, we must do our part to help patients get access to the treatments they require," Gottlieb said in a statement.

On Tuesday, the FDA said it will now give priority reviews to new generic drugs until there are at least three on the market. That's the level at which prices tend to drop sharply, up to 85% off the brand-name price.

The agency also published its first list of brand-name drugs that no longer have a patent's protection but don't yet have generic competition, a strategy to entice generic drugmakers to develop copycats.

The list includes an HIV medicine, a genetically engineered heart drug, prescription multivitamins and IV salt and sugar solutions. Some have been in short supply, sometimes for years, after quality problems shut down manufacturing lines or companies stopped making them to pursue more profitable products.

Among the best-known cases of dramatic price hikes: Mylan's fivefold increase for EpiPen's price and former pharmaceutical executive Martin Shkreli's Turing Pharmaceuticals raising the price of an old drug for a deadly infection more than 5,000%, to $750 per pill.

Meanwhile, the FDA has scheduled a July 18 meeting to discuss possible changes to its rules for approving generics, which inadvertently have enabled some makers of brand-name medicines to prevent or delay generic rivals.

(Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

  • Kristen Remington's Health Watch ReportsMore>>

  • It's OK to Use Nasal Spray Flu Vaccine Again, U.S. Panel Says

    It's OK to Use Nasal Spray Flu Vaccine Again, U.S. Panel Says

    Thursday, February 22 2018 11:02 AM EST2018-02-22 16:02:16 GMT
    Courtesy: MGN, CDCCourtesy: MGN, CDC

    FluMist is the only spray-in-the-nose vaccine on the market. It was first licensed in 2003 and is approved for healthy people ages 2 to 49.  

    More >>

    FluMist is the only spray-in-the-nose vaccine on the market. It was first licensed in 2003 and is approved for healthy people ages 2 to 49.  

    More >>
  • New Lice Treatment Clinic in Reno

    Wednesday, February 21 2018 3:03 AM EST2018-02-21 08:03:45 GMT

    Our KTVN newsroom often hears from concerned parents about the lice policy in area schools. Students are not sent home if they have lice since it is more of a nuisance than a serious health risk. If you child brings home the bugs, there is a new clinic to help treat the infestation. We take you to Lice Clinics of America – Reno.    

    More >>

    Our KTVN newsroom often hears from concerned parents about the lice policy in area schools. Students are not sent home if they have lice since it is more of a nuisance than a serious health risk. If you child brings home the bugs, there is a new clinic to help treat the infestation. We take you to Lice Clinics of America – Reno.    

    More >>
  • Preventive Treatment for Peanut Allergies Succeeds in Study

    Preventive Treatment for Peanut Allergies Succeeds in Study

    Tuesday, February 20 2018 11:23 AM EST2018-02-20 16:23:27 GMT

    The first treatment to help prevent serious allergic reactions to peanuts may be on the way. A company said Tuesday that its daily capsules of peanut flour helped sensitize children to nuts in a major study.

    More >>

    The first treatment to help prevent serious allergic reactions to peanuts may be on the way. A company said Tuesday that its daily capsules of peanut flour helped sensitize children to nuts in a major study.

    More >>
Powered by Frankly
All content © Copyright 2000 - 2018 Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.